FDA reveal EUA criteria – “No adequate, approved, and available alternative”

Dr. Doran Fink from the FDA explains at the July 29, 2020 ACIP meeting the criteria necessary for the FDA to be able to issue a COVID-19 vaccine with Emergency Use Authorisation (EUA).

The key point being that there has to be “No adequate, approved, and available alternative“. [@2:57]